Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FXJD3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,373
Award facts
- Contract value 100% obligated
- $14,373.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,373.37 for 30-count packages of Vraylar 1.5 mg capsules, a psychiatric medication used to treat conditions such as bipolar disorder and schizophrenia. This non-competitive, firm fixed-price delivery order is scheduled for completion by June 2, 2025, with performance at the company's Conshohocken, Pennsylvania headquarters. The award represents a routine pharmaceutical procurement under the Defense Health System's medical supply chain operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's selection reflects its demonstrated capability to meet federal procurement requirements through open competition across a diverse portfolio of medical products.
Quick answers
Who was awarded contract SPE2DB25FXJD3?
SPE2DB25FXJD3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FXJD3 worth?
The government has obligated $14,373 on SPE2DB25FXJD3.
Is contract SPE2DB25FXJD3 an order under another contract?
Yes. SPE2DB25FXJD3 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXJD3 competed?
The extent of competition for SPE2DB25FXJD3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award